EP 154 - Kristina Levan: Why Life-Saving Therapies Aren’t Reaching Patients—And How to Fix It

ATMPs, gene therapies, and cancer breakthroughs are here—but outdated regulations, high costs, and logistical bottlenecks are blocking access. What needs to change for hospitals to deliver these cures to patients who need them most? 💡 Here’s the harsh reality:Patients are waiting, but hospitals aren’t ready.The science exists, but regulations haven’t caught up.The treatments work, but they’re too expensive to scale. So what’s the solution? And who’s taking action? 📌 In this episode, Kristina Levan—ATMP innovation leader and biotech strategist—breaks down the challenges and opportunities shaping the future of advanced therapies. 🎧 Watch now to learn: 1️⃣ How gene therapy is curing blindness—and why it almost didn’t happen. 2️⃣ The biggest bottleneck preventing hospitals from offering life-saving treatments. 3️⃣ How AI and automation could unlock personalized medicine for everyone. 4️⃣ The real reason ATMPs are so expensive—and what must change. 5️⃣ Why healthcare leaders, policymakers, and investors must rethink how we manufacture cures. 👤 About Kristina Levan: Kristina Levan has spent years at the cutting edge of cancer research, clinical trials, and ATMP development. She’s helped shape Sweden’s national ATMP strategy, connecting industry, healthcare, and academia to push these breakthroughs forward. Now, she’s tackling the next big challenge—getting these treatments to patients faster. 💡 Quotes to Challenge Your Thinking: (00:12:05) "ATMPs don’t just treat symptoms—they have the power to cure diseases." (00:23:36) "Gene therapy is giving children a future—restoring sight and transforming their lives forever." (01:27:52) "Imagine a future where hospitals create customized gene therapies on-site for every patient." (01:43:13) "ATMPs could transform lives by treating the untreatable." (01:45:42) "If we can cure early, we don’t just save lives—we reshape them." Timestamps: (00:05:32) How ATMPs Will Reshape Global Healthcare (00:13:54) CAR-T Therapy: The Next Cancer Treatment Revolution (00:23:36) Gene Therapy Restores Sight—The Future of Medicine? (00:28:33) AI-Powered Therapies: Can Hospitals Manufacture Cures? (00:37:55) Why Cutting-Edge ATMPs Struggle to Reach Patients (00:53:36) Personalized Medicine & Real-Time Health Monitoring (01:09:02) From Research to Reality: Scaling ATMP Treatments (01:12:54) The True Cost of ATMPs—Can We Afford Innovation? (01:27:15) Cell Therapy Manufacturing: The Next Big Disruption (01:33:03) AI & Automation in Healthcare: What’s Next? 🔔 Help Us Grow If this episode gave you insight, inspiration, or a new perspective—here’s how you can help: 📢 Hit SUBSCRIBE, like, and leave a comment. It’s a small action, but it has a huge ripple effect. Every engagement helps us bring in bigger guests, deeper insights, and more industry-changing conversations. Right now, we’re in the global top 10%—let’s push for the top 1% together. 🎧 Watch now and be part of the conversation shaping the future of medicine. 🚀 Send us a text Support the show Join the Podcast Newsletter: Link